Taiwan provisionally approves dexamethasone to treat Covid-19

RTE
Date: 4 Aug 2020

Taiwan has decided to provisionally allow dexamethasone to be listed as a Covid-19 treatment\

Taiwan has provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat Covid-19.

It comes as the island faces a shortfall of the antiviral drug remdesivir, after the United States bought nearly all global supplies.

Taiwan Centres for Disease Control Deputy Director-General Chuang Jen-hsiang told reporters that medical experts had decided to provisionally allow dexamethasone to be listed as a Covid-19 treatment but that procedures still needed to be completed before it could be given to any patients.

Taiwan has reported 476 cases of the new coronavirus, including seven deaths.
[FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.